3-(3-Methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride

Catalog No. :
ACQKWH397
CAS No. :
2924463-72-7
Molecular Formula :
C24H34ClN5O3
Molecular Weight :
476.02

IUPAC Name:3-(3-methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride

3-(3-Methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(3-Methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride
IUPAC Name3-(3-methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride
Molecular FormulaC24H34ClN5O3
Molecular Weight476.02
SMILESCN1C(=O)N(C2CCC(=O)NC2=O)C2=CC=C(C3CCN(CC4CCNCC4)CC3)C=C21.Cl
InChI KeyACLOPJRIZGBZLI-UHFFFAOYSA-N
Synonym3-(3-Methyl-2-oxo-5-(1-(piperidin-4-ylmethyl)piperidin-4-yl)-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-2,6-dione hydrochloride;2,6-Piperidinedione, 3-[2,3-dihydro-3-methyl-2-oxo-5-[1-(4-piperidinylmethyl)-4-piperidinyl]-1H-benzimidazol-1-yl]-, hydrochloride (1:1)
CAS No.2924463-72-7

Synthetic Route by SureRoute

1. ACQKWH397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQKWH397 route product structure diagram
    ACQKWH3972924463-72-7
Inquiry

2. ACQKWH397 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQKWH397 route product structure diagram
    ACQKWH3972924463-72-7
Inquiry

Comments (0)